三级aa视频在线观看-三级国产-三级国产精品一区二区-三级国产三级在线-三级国产在线

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

China core market for US medical devices company

By Liu Zhihua in Shanghai | chinadaily.com.cn | Updated: 2024-11-08 15:24
Share
Share - WeChat

China remains a core market for Edwards Lifesciences, especially with the ongoing improvements in the country's business environment characterized by expanding foreign investment access and faster product reviews, a senior executive of the United States-based medical devices company said.

Ben Cheong, senior vice-president of Greater China Region at Edwards Lifesciences, reaffirmed at the 7th China International Import Expo in Shanghai the company's commitment to deepening its role in China's healthcare landscape, through initiatives like patient education, doctor training and taking part in the CIIE, an annual event in Shanghai.

Edwards entered China over two decades ago, but its debut at CIIE in 2020 marked a turning point, bringing broader recognition of its innovative solutions for patients fighting cardiovascular disease, he said.

"We are very optimistic about our growth in China and have a long-term vision for our development here," said Cheong.

He lauded China's supportive policies for new product introductions and health insurance, stating, "Accelerated review procedures for innovative medical devices have made regulatory approvals faster and more efficient. Edwards' transcatheter aortic valve has also been covered by the healthcare reimbursement in regions such as Henan, Shanghai and Beijing, increasing accessibility to our products."

Leveraging the platform of CIIE, the transcatheter aortic valve has been successfully adopted in 112 medical centers across 27 provinces and cities, benefiting over 2000 patients in China.

As China's aging population drives cardiovascular disease rates, heart valve disorders have become the country's third most common cardiac condition after hypertension and coronary artery disease. Data from the National Center for Cardiovascular Diseases showed that heart valve disease affected about 25 million people in China in 2022, and Orient Securities projected in a report that the number could reach 40.2 million by 2025.

Despite the large number of patients, heart valve disease in China is underdiagnosed, often detected late, with only one percent to two percent of patients receiving surgical intervention and interventional treatment rates lagging behind developed nations. This gap presents significant potential for growth, especially in transcatheter solutions for high-risk patients unable to undergo open-heart surgery.

"Edwards in China has continually kept pace with global advancements, accelerating the introduction of innovative structural heart disease products to benefit Chinese patients," Cheong said.

The mismatch between the demand for high-quality medical services and the current diagnostic and treatment landscape in China also highlights the need for progress in areas such as clinical education and health communication.

Since 2019, Edwards has collaborated with top Chinese hospitals and experts to elevate cardiac care standards. The Edwards Surgical Academy has conducted nearly 80 training and academic programs, covering over 3,900 cardiac surgeons and benefiting approximately 80,000 patients. Notably, through the Teaching Center of Excellence project, Edwards has established 10 training centers with 29 recognized experts across China, equipping local clinicians with advanced techniques and skills.

Edwards also works to promote heart valve health awareness and connect patients with educational resources. Through the "Every Heartbeat Matters" (EHM) initiative, the Edwards Lifesciences Foundation has provided medical aid and screenings to support disadvantaged heart valve patients in China, Cheong said.

"Looking ahead, we will continue our focus on the Chinese market," Cheong added. "Leveraging platforms like CIIE, we aim to consistently bring innovative products to China, collaborate with Chinese physicians to advance clinical care, and align closely with the country's healthcare development as a trusted partner."

Leng Zichun contributed to the story

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 国产精品www| 久久aaa| 国产永久一区二区三区 | 国产h视频在线观看高清 | 婷婷资源综合 | 国产美女白丝袜精品_a不卡 | 韩国黄色网 | 精品国产91久久久久久久a | 91视频免费网站 | 欧美视屏在线观看 | 成人午夜私人影院入口 | 久久毛片网 | 91久久国产成人免费观看资源 | 国产成人精品永久免费视频 | 亚洲国产国产综合一区首页 | 日韩伦理中文字幕 | 一级做a爰片性色毛片黄书 一级做a爰片性色毛片新版的 | 国产九九在线观看播放 | 免费碰碰碰视频在线看 | 免费视频网站一级人爱视频 | 免费成人福利视频 | 欧美日韩亚洲一区二区 | 一级毛片成人免费看免费不卡 | 亚洲国产精品一区二区不卡 | 91麻豆国产极品在线观看洋子 | 国产91福利 | 久久羞羞 | 欧美性生活视频播放 | 国产在线观看麻豆91精品免费 | 欧美综合激情网 | 欧美激情视频网址 | 真正国产乱子伦高清对白 | 国产麻豆免费观看 | va视频在线观看 | 九九精品激情在线视频 | 黄色资源在线观看 | 在线视频观看一区 | 国产精品久久久久毛片真精品 | 国产精品一区二 | 小明永久免费 | 精品视频麻豆网站 |